Conformationally constrained backbone cyclized somatostatin anal

Details Conformationally constrained backbone cyclized somatostatin anal Conformationally constrained backbone cyclized somatostatin anal

1998-06-19

2000-04-18

Woodward, Michael P.

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Peptide containing doai

514 14, 514 15, 514 16, 514 17, 514 18, 530311, 530317, 530327, 530328, 530329, 530330, A61K 3804, A61K 3812, C07K 764

Patent

active

060515546

ABSTRACT:
Novel peptides which are conformationally constrained backbone cyclized somatostatin analogs. Methods for synthesizing the somatostatin analogs and for producing libraries of the somatostatin analogs are also disclosed. Furthermore, pharmaceutical compositions comprising somatostatin analogs, and methods of using such compositions are disclosed.

REFERENCES:
patent: 3988304 (1976-10-01), Garsky
patent: 4011182 (1977-03-01), Sarantakis
patent: 4054558 (1977-10-01), Garsky
patent: 4187217 (1980-02-01), Chipens et al.
patent: 4235886 (1980-11-01), Freidinger et al.
patent: 4310518 (1982-01-01), Freidinger et al.
patent: 5364851 (1994-11-01), Joran
patent: 5371070 (1994-12-01), Koerber et al.
patent: 5770687 (1998-06-01), Hornik et al.
Bell et al., 1993, "Molecular biology of somatostatin receptors", TINS 16:34-38.
Brazeau et al, 1973, "Hypothalamic Polypeptide That Inhibits the Secretion of Immunoreactive Pituitary Growth Hormone", Science 179:77-79.
Buscail et al., 1995, "Inhibition of cell proliferation by the somatostatin analogue RC-160 is mediated by somatostatin receptor subtypes SSTR2 and SSTR5 through different mechanisms", Proc. Natl. Acad. Sci. USA 92:1580-1584.
Byk et al., 1992, "Building Units for N-Backbone Cyclic Peptides. 1. Synthesis of Protected N-(.omega.-Aminoalkylene)amino Acids and Their Incorporation into Dipeptide Units", J. Org. Chem. 57:5687-5692.
Charpentier et al., 1989, "Synthesis and Binding Affinities of Cyclic and Related Linear Analogues of CCK.sub.8 Selective for Central Receptors", J. Med. Chem. 32:1184-1190.
Giannis et al., 1993, "Peptidomimetics for Receptor Ligands--Discovery, Development, and Medical Perspectives", Angew. Chem. Int. Ed. Engl. 32:1244-1267.
Gilon et al., 1992, "SAR studies of cycloseptide: Effects of cyclization and charge at position 6", Chem. Biol. Proc Am Pept Symp 12th. pp. 476-477.
Gilon et al., 1991, "Backbone Cyclization: A New Method for Conferring Conformational Constraint on Peptides", Biopolymers 31:745-750.
Greiner et al., "Synthesis of New Backbone-Cyclized Bradykinin Analogs", Pept. 1994, Proc.Eur.Pept.Symp. 23rd Meeting Date 1994, 289-290.
Hruby et al., 1990, "Emerging approaches in the molecular design of receptor-selective peptide ligands: conformational, topographical and dynamic considerations", Biochem. J. 268:249-262.
Krstenansky et al., "Cyclic hexapeptide antagonists of the bradykinn B.sub.2 receptor: Receptor binding and solution backbone conformation", Letters in Peptide Science, vol. 1 (1994) pp. 229-234.
Lamberts et al., 1990, "Somatostatin-Receptor Imaging in the Localization of Endocrine Tumors", New England J. Med. 323:1246-1249.
Lamberts, 1988, "The Role of Somatostatin in the Regulation of Anterior Pituitary Hormone Secretion and the Use of Its Analogs in the Treatment of Human Pituitary Tumors", Endocrine Reviews 9:417-436.
Lymangrover et al, 1983, "Varying the Duration of A23187 Administration Alters its Effect on Adrenal Steroidogenesis", Life Sciences 34:371-377.
Mosberg et al., 1983, "Bis-penicillamine enkephalins possess highly improved specificity toward Oopioid receptors", Proc. Natl. Acad. Sci. USA 80:5871-5874.
Plotsky et al., 1985, "Patterns of Growth Hormone-Releasing Factor and Somatostatin Secretion into the Hypophysial-Portal Circulation of the Rat", Science 230:461-463.
Raynor et al., 1993, "Cloned Somatostatin Receptors: Identification of Subtype-Selective Peptides and Demonstration of High Affinity Binding of Linear Peptides", Mol. Pharmacol. 43:838-844.
Reisine et al., 1995, "Molecular Biology of Somatostatin Receptors", Endocrine Reviews 16:427-442.
Reubi et al., 1995, "Multiple actions of somatostatin in neoplastic disease", TIPS 16:110-115.
Rizo et al., 1992, "Constrained Peptides: Models of Bioactive Peptides and Protein Substructures", Annu. Rev. Biochem. 61:387-418.
Rodriguez et al., 1990, "Synthesis of cyclic analogues of cholecystokinin highly selective for central receptors", Int. J. Peptide Protein Res. 35:441-451.
Rudinger, 1976, "Characteristics of the Amino Acids as Components of a Peptide Hormone Sequence in Peptide Hormones" (ed. J.A. Parsons), University Park Press, Baltimore, pp. 1-7.
Steranka et al., 1988, "Bradykinin as a pain mediator: Receptors are localized to sensory neurons, and antagonists have analgesic actions", Proc. Natl. Acad. Sci. USA 85:3245-3249.
Veber et al., 1984, "A Super Active Cyclic Hexapeptide Analog of Somatostatin", Life Sciences 34:1371-1378.
Veber et al., 1985, "The design of metabolically-stable peptide analogs", TINS pp. 392-396.
Zuckerman, 1993, "The chemical synthesis of peptidomimetic libraries", Current Opinion in Structural Biol. 3:580-584.

Affiliated with

Also associated with

Rating

Conformationally constrained backbone cyclized somatostatin anal does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Conformationally constrained backbone cyclized somatostatin anal, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Conformationally constrained backbone cyclized somatostatin anal will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2336408